Insider Stock Trading History of Blight Andrew


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Blight Andrew since year 2005. The trader's CIK number is 1352453. At the time of this reporting, Blight Andrew is the Chief Scientific Officer of Acorda Therapeutics Inc . (stock ticker symbol ACOR). See this page for all insider trading activities at Acorda Therapeutics Inc .


Stock purchases, sales, and option exercises reported by insider Blight Andrew since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-02-09 ACOR Acorda Therapeutics Inc Sale 67,586 22.41 1,514,399
2017-02-09 ACOR Acorda Therapeutics Inc Option Ex 67,586 22.13 1,495,678
2016-08-09 ACOR Acorda Therapeutics Inc Option Ex 9,754 22.13 215,856
2015-11-20 ACOR Acorda Therapeutics Inc Option Ex 500 8.50 4,250
2015-11-20 ACOR Acorda Therapeutics Inc Sale 500 37.47 18,735
2015-10-19 ACOR Acorda Therapeutics Inc Sale 32,500 31.03 1,008,540
2015-10-19 ACOR Acorda Therapeutics Inc Option Ex 32,500 5.85 190,125
2015-09-21 ACOR Acorda Therapeutics Inc Option Ex 13,085 6.00 78,510
2015-09-21 ACOR Acorda Therapeutics Inc Sale 13,085 31.33 409,953
2014-10-20 ACOR Acorda Therapeutics Inc Option Ex 52,338 8.14 426,031
2014-10-20 ACOR Acorda Therapeutics Inc Sale 52,338 32.08 1,678,793
2013-12-02 ACOR Acorda Therapeutics Inc Sale 9,088 33.51 304,566
2013-07-19 ACOR Acorda Therapeutics Inc Option Ex 19,296 2.60 50,169
2013-07-19 ACOR Acorda Therapeutics Inc Sale 19,296 37.82 729,774
2012-12-03 ACOR Acorda Therapeutics Inc Sale 7,200 24.20 174,247
2012-10-22 ACOR Acorda Therapeutics Inc Option Ex 9,481 2.60 24,650
2012-10-22 ACOR Acorda Therapeutics Inc Sale 9,481 23.08 218,821
2011-12-01 ACOR Acorda Therapeutics Inc Sale 7,000 22.92 160,440
2010-03-02 ACOR Acorda Therapeutics Inc Sale 4,173 32.21 134,408
2010-02-02 ACOR Acorda Therapeutics Inc Sale 4,534 30.00 136,020
2009-12-01 ACOR Acorda Therapeutics Inc Sale 4,500 24.51 110,277
2008-06-12 ACOR Acorda Therapeutics Inc Sale 9,200 30.67 282,145
2008-06-12 ACOR Acorda Therapeutics Inc Option Ex 29,200 2.60 75,920
2008-06-12 ACOR Acorda Therapeutics Inc Sale 8,900 31.00 275,855
2007-06-12 ACOR Acorda Therapeutics Inc Sale 500 31.05 15,525
2008-06-12 ACOR Acorda Therapeutics Inc Sale 8,800 31.48 277,041
2008-06-12 ACOR Acorda Therapeutics Inc Sale 1,800 31.73 57,110
2008-06-11 ACOR Acorda Therapeutics Inc Option Ex 800 2.60 2,080
2008-06-11 ACOR Acorda Therapeutics Inc Sale 800 31.54 25,228
2008-06-05 ACOR Acorda Therapeutics Inc Sale 3,700 30.40 112,468
2008-06-05 ACOR Acorda Therapeutics Inc Sale 7,000 32.21 225,484
2008-06-05 ACOR Acorda Therapeutics Inc Sale 4,000 31.78 127,124
2008-06-05 ACOR Acorda Therapeutics Inc Sale 5,300 32.56 172,546
2008-06-05 ACOR Acorda Therapeutics Inc Option Ex 20,000 2.60 52,000
2008-04-07 ACOR Acorda Therapeutics Inc Sale 3,586 18.39 65,953
2008-03-10 ACOR Acorda Therapeutics Inc Sale 4,000 17.93 71,704
2008-02-15 ACOR Acorda Therapeutics Inc Option Ex 4,487 2.60 11,666
2008-02-15 ACOR Acorda Therapeutics Inc Sale 4,487 23.38 104,915
2008-01-15 ACOR Acorda Therapeutics Inc Sale 3,586 23.04 82,625
2007-12-10 ACOR Acorda Therapeutics Inc Sale 4,000 20.38 81,504
2007-11-15 ACOR Acorda Therapeutics Inc Sale 5,865 18.27 107,153
2007-10-15 ACOR Acorda Therapeutics Inc Option Ex 4,487 2.60 11,666
2007-10-15 ACOR Acorda Therapeutics Inc Sale 3,366 20.24 68,134
2007-09-10 ACOR Acorda Therapeutics Inc Sale 4,000 16.05 64,191
2007-08-17 ACOR Acorda Therapeutics Inc Option Ex 6,410 2.60 16,666
2007-08-17 ACOR Acorda Therapeutics Inc Sale 3,044 18.05 54,944
2007-06-08 ACOR Acorda Therapeutics Inc Sale 3,040 18.50 56,240
2006-12-11 ACOR Acorda Therapeutics Inc Sale 2,500 16.93 42,314
2006-11-30 ACOR Acorda Therapeutics Inc Sale 641 19.52 12,509
2006-11-07 ACOR Acorda Therapeutics Inc Sale 15,900 15.73 250,091
2006-11-07 ACOR Acorda Therapeutics Inc Sale 14,100 15.22 214,644
2006-11-06 ACOR Acorda Therapeutics Inc Sale 25,000 16.07 401,825

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Blight Andrew (Chief Scientific Officer of Acorda Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.